Stable nanoparticle formulations

Details for Australian Patent Application No. 2006336414 (hide)

Owner Sanofi-Aventis U.S. LLC

Inventors Abu-Izza, Khawla Abdullah

Agent Watermark

Pub. Number AU-B-2006336414

PCT Pub. Number WO2007/086911

Priority 60/678,086 05.05.05 US

Filing date 3 May 2006

Wipo publication date 2 August 2007

Acceptance publication date 24 November 2011

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 47/44 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Oils, fats or waxes according to more than one of groups

Event Publications

29 November 2007 PCT application entered the National Phase

  PCT publication WO2007/086911 Priority application(s): WO2007/086911

24 November 2011 Application Accepted

  Published as AU-B-2006336414

22 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006336417-Nanoparticulate clopidogrel formula- tions

2006336412-Carbon composite materials and methods of manufacturing same